Tapinarof for Plaque Psoriasis: Usage, Pharmacology, and Side Effects

Overview:

Tapinarof, a non-steroidal topical medication, is prescribed for the management of plaque psoriasis. The drug is used for moderate to severe psoriasis forms as it reduces inflammation effectively. The drug is well tolerated and does not produce severe adverse reactions. Clinical studies show that Tapinarof cream, when used as per prescription, improves skin health and enhances the quality of life in individuals with plaque psoriasis.

Is Tapinarof FDA Approved?

In May 2022, the United States Food and Drug Administration (USFDA) authorized Tapinarof as a proven treatment for plaque psoriasis, especially in people who are 18 years or older. As the first agent of its type, Tapinarof FDA approval is a nonsteroidal topical medication that falls under the special family of naturally generated aryl hydrocarbon receptor (AhR) agonists, setting it apart from steroid-based therapies.

Drug Group:

Tapinarof is an aryl hydrocarbon receptor agonist used for topical treatment of plaque psoriasis.

Available Doses and Dosage Forms:

Dosage Form: Cream.

Strength: One percent concentration.

For Patients:

What Is Tapinarof Used For?

• Topical Tapinarof treats plaque psoriasis, a skin condition characterized by red, scaly patches that appear on specific body parts. Tapinarof is classified under the aryl hydrocarbon receptor agonists. The exact mechanism of action of topical Tapinarof in the treatment of plaque psoriasis is not known.

• Tapinarof is applied topically as a cream. It is generally given once daily. Use Tapinarof at around the same time every day.

• Follow the instructions on the prescription label carefully, and clarify with a pharmacist or doctor any information you do not understand. Use Tapinarof exactly as prescribed by your doctor. Do not take more or less of it, nor use it more often than prescribed.

How Does Tapinarof Work?

A new topical medication called Tapinarof was created, especially for plaque psoriasis treatment. It performs the job of an aryl hydrocarbon receptor (AhR) agonist, activating a particular skin receptor that is essential for controlling immunological responses and the behavior of skin cells.

Applying Tapinarof to the skin aids in reestablishing the proper balance between skin cell proliferation and differentiation. Tapinarof decreases inflammation and regulates the immune system by activating the AhR, which also results in a reduction in the excessive skin cell proliferation that is specific to psoriasis. Unlike conventional therapies like corticosteroids and vitamin D analogs, which frequently have more extensive effects on the immune system and might cause negative effects with prolonged usage, this method is unique. Because of its distinct mode of action, patients looking for a non-steroidal medication or who might not respond well to traditional medicines have another choice.

What Is the Dosage of Tapinarof?

For people with plaque psoriasis, the suggested dosage of Tapinarof is simple, but it should always be used under a doctor's supervision. The following are the main details of its dosage:

• Apply a thin coating of one percent Tapinarof cream immediately to the skin's afflicted regions. For best absorption, ensure the cream is evenly applied throughout the plaques.

• Usually, the cream is used once a day. Patients should make an effort to apply it at the same time every day since consistency is essential for getting the best results.

• Many individuals may continue using Tapinarof until they see a noticeable improvement in their condition, while the length of therapy might vary depending on individual reaction and the severity of the condition.

Missed Dose:

As soon as recalled, apply the missing dosage. Do not take the missing dosage if the next planned dose is almost here. Never submit a second application to make up for a missed one. Try to create a habit of using Tapinarof at the same time every day for the best benefits. This can reduce the likelihood of skipping a dosage.

Overdose:

• Symptoms: Although systemic overdose from topical drugs such as Tapinarof is unusual, overuse may result in increased skin irritation or other negative responses.

• Take Action: Contact the healthcare practitioner or seek emergency medical treatment right away if one suspects an overdose or suffers severe adverse effects. They can offer advice on the best path of action.

How Effective Is Tapinarof?

Clinical studies and research on Tapinarof have shown promising results in the treatment of plaque psoriasis. These studies also have proven that a few patients see a slight improvement in their health after using Tapinarof. Significant study findings about its efficacy are as follows:

• Clinical Studies: After 12 weeks of therapy, several patients in crucial clinical studies saw virtually clean or clear skin, while many others saw a decrease in the severity of their plaques. The outcomes showed improvements in related symptoms such as itching and pain in addition to a reduction in plaque thickness and scaling.

• Long-Term Use: Patients who consistently use Tapinarof have seen long-lasting improvements, which proves that the medication can be beneficial for the long-term management of plaque psoriasis. Regularly following up with medical professionals can assist in determining continued efficacy and making any required modifications.

What Are the Things to Inform the Doctor Before Taking the Drug?

The following must be disclosed to the healthcare practitioner before beginning Tapinarof treatment:

• Medical History: Inform about past allergies, skin disorders, or other health problems. This covers past psoriasis treatments as well as any negative drug effects.

• Current Medication: Provide a detailed list of all prescription and over-the-counter medicines, herbal remedies, and supplements used. This will aid the doctor in evaluating possible interactions.

• Pregnancy and Breastfeeding: Tell the doctor whether you are currently nursing a baby or want to get pregnant soon. It is important to discuss Tapinarof's safety during pregnancy and nursing.

• Skin Disorders: Please disclose any open wounds, infections, or other skin disorders. Tapinarof should not be used on skin that is already damaged.

• Allergies: Let the doctor know if having any known allergies, especially to any chemicals in Tapinarof or topical treatments.

How Is Tapinarof Administered?

Tapinarof is used topically, and its efficacy is maximized only when applied correctly. The steps for administration are as follows:

• Preparation: Before applying, make sure the afflicted region of the skin is clean and dry. Wash your hands well both before and after using the lotion.

• Application: Apply a tiny bit of the one percent Tapinarof cream to your fingers. Directly apply a small coating to the skin's afflicted regions. Gently massage it in until it is uniformly spread.

• Regularity: Use Tapinarof once a day, ideally at the same time every day, to maintain consistency.

• Avoid Sensitive Areas: Do not apply the cream to the eyes, mucous membranes, or open wounds. If contact occurs, rinse with water thoroughly.

What Are the Benefits of Tapinarof?

Tapinarof offers a variety of benefits:

Efficacy: Tapinarof is effective in treating psoriasis and atopic dermatitis by altering the aryl hydrocarbon receptor (AhR) to reduce proinflammatory cytokines and regulate skin barrier proteins.

Safety: Tapinarof is a very safe treatment for psoriasis. It is well-tolerated and not associated with a few systemic side effects.

Long-Term Remission: In patients with psoriasis, Tapinarof has been proven to produce persistent remission or near-remission, lasting on average 130 days after the medication is discontinued.

Convenience: Patients have a convenient treatment option with Tapinarof cream, which is used once daily.

What Are the Side Effects of Tapinarof?

The most frequent side effects (incidence ≥ one percent) among patients using Tapinarof cream were:

• Skin Irritation: At the application site, users may suffer localized skin irritation that looks like redness, burning, or itching. This is frequently minor and might go away with regular use.

• Dry Skin: Certain people may notice a greater degree of dryness in the treated regions. It is essential to monitor skin conditions and modify usage as needed.

• Folliculitis: Tiny, red pimples or pustules may result from inflammation of the hair follicles. Usually, they go away on their own, but if they persist, a doctor's advice may be needed.

• Erythema: Sensitive people are more likely to have widespread skin redness. Talk to a physician if this gets serious or troublesome.

• Influenza: This illness can cause severe pain with symptoms like fever, coughing, sore throat, and body aches.

• Nasopharyngitis: Often resulting in mild to severe sickness, it can cause a runny nose, painful throat, and sneezing.

• Contact Dermatitis: It results from exposure to allergens or irritants in skin that are red, itchy, and inflammatory.

• Pruritus: A chronic itching feeling that can cause skin damage and scratches if left untreated.

Dietary Considerations:

There are no dietary requirements, yet eating a balanced diet can improve skin health in general. Adapt these while using Tapinarof:

• Hydration: Keeping the skin hydrated with lots of water will help reduce some of the dryness that comes with topical treatments.

• Nutrient-Rich Foods: Including foods high in antioxidants (like fruits and vegetables), omega-3 fatty acids (like fish and flaxseeds), and vitamins (particularly C and E) can help maintain healthy skin.

• Steer Clear of Triggers: Some psoriasis sufferers discover that eating particular foods can set off flare-ups. Maintaining a food journal might be beneficial in determining any dietary triggers unique to the illness.

Storage

• Tapinarof psoriasis cream should be kept between 68 degrees Fahrenheit and 77 degrees Fahrenheit (20 degrees Celsius and 25 degrees Celsius) at room temperature.

• Refrain from freezing Tapinarof cream.

• Keep Tapinarof cream away from intense heat sources.

• Keep any medications, including Tapinarof cream, out of children's reach.

For Doctors:

Indication:

An aryl hydrocarbon receptor agonist called Tapinarof cream, one percent, is recommended for the topical treatment of adult plaque psoriasis.

Dose:

Apply a thin layer of Tapinarof cream (0.3 percent) to the affected areas once daily.

Dosing Considerations:

• Application: Before using the cream, make sure the skin is clean and dry. Gently massage it until the cream is fully absorbed into the affected regions.

• Duration of Use: Continue taking Tapinarof for the full recommended duration from the doctor, which is usually up to 12 weeks or as needed, depending on the reaction.

• Avoid Sensitive Regions: Unless instructed by a healthcare professional, avoid using Tapinarof on sensitive regions like the face, underarms, or groin.

• Monitoring: Check in with the doctor regularly to evaluate the efficacy and any possible adverse effects.

• Discontinuation: Speak with the doctor about lowering the frequency of application or stopping treatment if severe irritation develops.

What Are the Pharmacological Aspects of Tapinarof?

1. Pharmacodynamics

It is uncertain what Tapinarof cream's pharmacodynamic features are,

• Electrophysiology of the Heart: Tapinarof does not extend the QTc interval to any clinically significant degree when taken at the authorized recommended dosage.

2. Mechanism

Tapinarof's mechanism of action is the aryl hydrocarbon receptor (AhR), which is essential for controlling several biological functions like the immune system and skin homeostasis and is selectively agonistic of Tapinarof. Through AhR activation, Tapinarof facilitates altering the way that pro-inflammatory cytokines are expressed. It reduces the growth of keratinocytes, which is necessary to lessen the thicker plaques that are hallmarks of psoriasis. Furthermore, it also encourages skin cell differentiation, which will improve skin health.

3. Pharmacokinetics

• Absorption: When applied topically to undamaged skin, Tapinarof has little systemic absorption because it is intended for topical use. This localized impact reduces the possibility of systemic side effects.

• Distribution: After topical application, Tapinarof mostly stays in the skin's upper layers, where it acts as a medication.

• Metabolism: Because Tapinarof is poorly absorbed, its metabolism is primarily confined to the skin and happens locally.

• Excretion: Due to its low systemic exposure, Tapinarof is mostly excreted through the skin, not the kidneys or liver.

Toxicity:

• Localized Skin Responses: Localized skin responses, such as erythema, burning, and itching at the application site, are the most frequent harmful consequences linked to Tapinarof. The majority of the time, these responses are moderate and go away, irrespective of whether the medication is continued or briefly stopped.

• Systemic Toxicity: Tapinarof has a low risk of systemic toxicity because of its poor systemic absorption. However, patients should be kept an eye out for any strange or serious responses.

Clinical Studies:

• Effectiveness: Tapinarof has been shown in clinical trials to be successful in lowering the severity of plaque psoriasis, as seen by the notable reductions in PASI (Psoriasis Area and Severity Index) scores.

• Safety Profile: According to research, Tapinarof is usually well-tolerated. The majority of side effects are mild to moderate and mostly confined to the application site.

• Treatment Length: Study participants often took Tapinarof for up to 12 weeks, and they demonstrated continued safety and efficacy over this time.

Warnings and Precautions:

• Localized Skin Responses: Erythema, burning, or itching should be kept an eye out. Consider stopping the drug if serious reactions happen.

• Use in Sensitive Areas: Avoid applying Tapinarof to sensitive regions such as the face, underarms, or groin unless instructed to do so by a healthcare professional.

• Pregnancy and Lactation: Caution should be exercised while using in pregnant or nursing women. To balance the advantages with any possible hazards, speak with a healthcare professional.

• Not for Ophthalmic Use: Application of Tapinarof to the eyes or mucous membranes is not advised; it is solely intended for topical usage.

What Are the Drug Interactions of Tapinarof?

• Topical Drugs: Use of Tapinarof in combination with other topical drugs should be done with caution, as this may raise the risk of irritation or unfavorable effects.

• Systemic Drugs: Systemic drugs are unlikely to cause major drug interactions because of their low absorption into the body; yet, it is still advisable to always disclose all medications used to healthcare practitioners.

Specific Considerations:

• Pregnancy: Use Tapinarof with caution. It is prescribed only if benefits exceed risks; little safety information is available on its usage in expectant women.

• Breastfeeding: Limited data available about Tapinarof usage in lactating women. See a healthcare professional for further information about excretion in breast milk.

• Child Safety and Effectiveness: Not designed for anyone under the age of eighteen; typically not advised until instructed.

• Geriatric: No special dose modification is required, although elderly patients may be more vulnerable to skin problems, so keep a close eye on them.